Free press releases distribution network?

Agency / Source: Genedata

Check Ads Availability|e-mail Article


Are you the owner of this article?, Turn it PREMIUM with your LOGO instead - and make it 3rd party Ads-Free! within the next hour!



Genedata Announces Expressionist Migration Program for Microarray and Mass Spectrometry Projects - Genedata Expressionist® System bundled with professional services to address emerging market needs for migration programs
Genedata Announces Expressionist Migration Program for Microarray and Mass Spectrometry Projects

 

PRZOOM - /newswire/ - Basel, Switzerland, 2009/07/28 - Genedata Expressionist® System bundled with professional services to address emerging market needs for migration programs.

   
 
Your Banner Ad Here instead - Showing along with ALL Articles covering Pharma/BioTech/Nutrition Announcements

Replace these Affiliate Programs at ANYTIME! Your banner here within the next hour. Learn How!


 

Genedata, a leading provider of in silico solutions for pharmaceutical R&D and related life sciences, today announced the Expressionist Migration Program, a new offering that bundles the Genedata Expressionist system with a targeted set of professional services. The Expressionist Migration Program provides researchers and bioinformaticians with a proven set of tools and services for the migration of microarray, mass spectrometry and related data from legacy and proprietary systems.

“While the landscape of bioinformatics vendors is ever-changing, the research process must continue uninterrupted,” said Dr. Othmar Pfannes, CEO of Genedata. “The Expressionist Migration Program is an offering packaged specifically for those researchers whose organizations may be in a state of flux due to new market conditions. As an employee-owned company, not affiliated with another entity, Genedata uniquely offers its customers an established and scalable portfolio of drug discovery and life science research solutions, professional services, and ongoing support,” continued Pfannes. “Expressionist Migration provides a practical transition path for customers looking for a cost-effective and efficient solution, which accelerates the time to value and ensures returns on previous investments.”

Expressionist Migration
The Expressionist Migration Program offers special terms on bundled software and professional services tailored to support smooth transition of internal or third-party data sources into Genedata Expressionist. Built upon an open and scalable architecture, Genedata Expressionist is an enterprise solution, which integrates, stores and analyzes transcriptomics, proteomics, and metabolomics data as well as a variety of phenotypic data. With the Genedata Expressionist Database as its foundation, Expressionist consists of several modules supporting high throughput, standardized and workflow-based data processing and statistical analysis. Its modular, three-tier architecture seamlessly integrates with a wide range of pharmaceutical, biotechnological, and agricultural R&D processes.

To support end users during the transition period, the Expressionist Migration Program also provides a portfolio of professional services spanning expert or administrative training, scientific consulting, and custom software development.

About Genedata
Genedata (genedata.com) develops and globally markets sophisticated computational solutions for drug discovery and related research processes in the life sciences. Genedata’s solutions enable scientists to process, integrate, analyze, and manage large and complex experimental data sets generated by high throughput technologies. Solutions include Genedata Phylosopher® for target discovery and integrative biological data management, Genedata Screener® for automated high throughput screening and high content screening, and Genedata Expressionist® for biomarker discovery and personalized medicine. Founded in 1997, Genedata is privately held, with headquarters in Basel, Switzerland, and offices in Boston & San Francisco, USA, Konstanz & Munich, Germany and Tokyo, Japan.

Contacts
Jackie Thrasivoulos, Genedata Public Relations
P:+1 508 881 3109
E: jackie.thrasivoulos[.]genedata.com

Disclaimer
The statements in this press release that relate to future plans, events or performance are forward-looking statements that involve risks and uncertainties, including risks associated with uncertainties related to contract cancellations, developing risks, competitive factors, uncertainties pertaining to customer orders, demand for products and services, development of markets for the Company's products and services. Readers are cautioned not to place undue reliance on these forward-looking statements, which speak only as of the date hereof. The Company undertakes no obligation to release publicly the result of any revisions to these forward-looking statements that may be made to reflect events or circumstances after the date hereof or to reflect the occurrence of unanticipated events.

All product and service names mentioned are the trademarks of their respective companies.

 
 
Your Banner Ad Here instead - Showing along with ALL Articles covering Pharma/BioTech/Nutrition Announcements

Replace these Affiliate Programs at ANYTIME! Your banner here within the next hour. Learn How!


 

Agency / Source: Genedata

 
 

Availability: All Regions (Including Int'l)

 

Traffic Booster: [/] Quick PRZOOM - Press & Newswire Visibility Checker

 

Distribution / Indexing: [+]

 
 
# # #
 

 
  Your Banner Ad showing on ALL
Pharma/BioTech/Nutrition articles,
CATCH Visitors via Your Competitors Announcements!


Genedata Announces Expressionist Migration Program for Microarray and Mass Spectrometry Projects

Company website links NOT available to basic submissions
It is OK to republish and/or LINK any newswire for any legitimate media purpose as long as you name PRZOOM - Press & Newswire and LINK as the source.
 
  For more information, please visit:
Is this your article? Activate ALL web links by Upgrading to Press Release PREMIUM Plan Now!
|
Contact: Allison Kurz - Genedata.com 
+41 61 511 8459 communications[.]genedata.com
 
PRZOOM / PRTODAY - Newswire Today disclaims any content contained in this article. If you need/wish to contact the company who published the current release, you will need to contact them - NOT us. Issuers of articles are solely responsible for the accuracy of their content. Our complete disclaimer appears here.
IMPORTANT INFORMATION: Issuance, publication or distribution of this press release in certain jurisdictions could be subject to restrictions. The recipient of this press release is responsible for using this press release and the information herein in accordance with the applicable rules and regulations in the particular jurisdiction. This press release does not constitute an offer or an offering to acquire or subscribe for any Genedata securities in any jurisdiction including any other companies listed or named in this release.

Pharma/BioTech/Nutrition via RSSAdd NewswireToday - PRZOOM Headline News to FeedBurner
Find who RetweetFollow @NewswireTODAY



Are you the owner of this article?, Turn it PREMIUM with your LOGO instead - and make it 3rd party Ads-Free! within the next hour!




Read Latest Press Releases From Genedata / Company Profile


Read Pharma/BioTech/Nutrition Most Recent Related Press Releases:

Ipsen Announces Phase 3 CELESTIAL Trial of Cabozantinib Meets Primary Endpoint of Overall Survival
First Patient Treated with Microscopic Beads Pre-loaded with A Targeted Cancer Drug and Visible on CT Scans
BTG Plc Acquires Roxwood Medical
BTG and Mirada Medical Sign Three-Year Software Development Agreement
U.S. FDA Approves New Indication for Ipsen’s Somatuline® Depot (lanreotide) Injection for the Treatment of Carcinoid Syndrome
Genentech Provides Update on First Lampalizumab Phase III Study for Geographic Atrophy, an Advanced Form of Age-Related Macular Degeneration
mProve Health and Greenphire Partner to Deliver a First-of-its-Kind Patient Engagement Solution
FDA Approves Genentech’s Actemra (Tocilizumab) for the Treatment of CAR T Cell-Induced Cytokine Release Syndrome
Greenphire Named to Inc. 5000 for Fifth Consecutive Year
Five Community Health Centers Honored for Innovative Approaches to Medication Therapy Management

Boost Your Social Network
& Crowdfunding Campaigns


LIFETIME SOCIAL MEDIA WALL
 
NewswireToday Celebrates 10 Years in Business
Find business coaching, life coaching, executive coaching and corporate coaching, best selling coaching books, ...



PREMIUM Members


Visit  JobsWare.com

Visit  BizJobs.com

Visit  RightITnow Ltd







 
  ©2017 PRZOOM — Limelon Advertising, Co.
Home | About PRZOOM | Advertise/Pricing | Contact | Investors | Privacy/TOS | Sitemap | FRANCAIS
newswire, PR press releases distribution service magazines engine news alert newsroom press room breaking news public relations articles company news alerts newswiredistribution ezine bizentrepreneur biznewstoday digital business report market search pr firms agencies reports distri-bution today investor relation successful internet entrepreneur newswire distribution prtoday.com freenewswiredistribution asianewstoday bizwiretoday USA pr UK today